Literature DB >> 18612803

Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats.

Takafumi Morisaki1, Takanobu Matsuzaki, Koji Yokoo, Masahiro Kusumoto, Kazufumi Iwata, Akinobu Hamada, Hideyuki Saito.   

Abstract

PURPOSE: The purpose of this study was to examine the regulation of renal organic ion transporters in cisplatin-induced acute kidney injury (AKI) and its relation with indoxyl sulfate (IS), a uremic toxin.
METHODS: The IS concentrations in the serum and kidney were monitored by high-performance liquid chromatography. Uptake of p-aminohippuric acid, estrone-3-sulfate and tetraethylammonium were examined using renal slices. Real-time PCR and immunoblotting were performed to examine the mRNA and protein expression of rOATs, rOCTs and rMATE1 in the kidney, respectively.
RESULTS: The serum and renal IS levels were markedly elevated in cisplatin-treated rats. However, this effect was largely reversed by administration of AST-120, an oral charcoal adsorbent. The functions of renal basolateral organic anion and cation transporters were reduced in cisplatin-treated rats. The levels of mRNA and protein corresponding to rOAT1, rOAT3, rOCT2 and rMATE1, but not rOCT1, were depressed in the kidney of cisplatin-treated rats. Administration of AST-120 to cisplatin-treated rats partially restored the function and expression level of these transporters.
CONCLUSIONS: Cisplatin-induced AKI causes down-regulation of renal organic ion transporters accompanied by accumulation of serum and renal IS. IS could be involved in the mechanism of down-regulation of rOAT1, rOAT3 and rMATE1 under cisplatin-induced AKI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612803     DOI: 10.1007/s11095-008-9668-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

Review 1.  Renal secretion of organic anions and cations.

Authors:  J B Pritchard; D S Miller
Journal:  Kidney Int       Date:  1996-06       Impact factor: 10.612

2.  Study of cyclooxygenase-2 in renal ischemia-reperfusion injury.

Authors:  M Matsuyama; R Yoshimura; T Hase; Y Kawahito; H Sano; T Nakatani
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

3.  An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.

Authors:  T Miyazaki; I Aoyama; M Ise; H Seo; T Niwa
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

4.  Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats.

Authors:  Kumiko Nishihara; Satohiro Masuda; Lin Ji; Toshiya Katsura; Ken-Ichi Inui
Journal:  Biochem Pharmacol       Date:  2007-01-09       Impact factor: 5.858

5.  Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.

Authors:  Tsuneo Deguchi; Sumio Ohtsuki; Masaki Otagiri; Hitomi Takanaga; Hiroshi Asaba; Shinobu Mori; Tetsuya Terasaki
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

6.  Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure.

Authors:  Kazufumi Iwata; Hiroshi Watanabe; Takafumi Morisaki; Takanobu Matsuzaki; Takafumi Ohmura; Akinobu Hamada; Hideyuki Saito
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

7.  Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.

Authors:  T Niwa; M Ise
Journal:  J Lab Clin Med       Date:  1994-07

8.  Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.

Authors:  Lin Ji; Satohiro Masuda; Hideyuki Saito; Ken-ichi Inui
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

9.  Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption.

Authors:  Y K Kim; H S Byun; Y H Kim; J S Woo; S H Lee
Journal:  Toxicol Appl Pharmacol       Date:  1995-01       Impact factor: 4.219

10.  Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.

Authors:  Takanobu Matsuzaki; Takafumi Morisaki; Wakako Sugimoto; Koji Yokoo; Daisuke Sato; Hiroshi Nonoguchi; Kimio Tomita; Tomohiro Terada; Ken-ichi Inui; Akinobu Hamada; Hideyuki Saito
Journal:  Drug Metab Dispos       Date:  2008-01-07       Impact factor: 3.922

View more
  14 in total

1.  Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.

Authors:  Hideyuki Saito; Misato Yoshimura; Chika Saigo; Megumi Komori; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Ayaka Wakida; Erina Chuman; Kazuhiko Nishi; Hirofumi Jono
Journal:  Toxicol Sci       Date:  2014-06-23       Impact factor: 4.849

2.  Cisplatin nephrotoxicity in male beagle dogs: next-generation protein kidney safety biomarker tissue expression and related changes in urine.

Authors:  J E McDuffie; Y Chen; J Y Ma; S Lee; K M Lynch; D M Hamlin; L Nguyen; M Rizzolio; M Sonee; S Snook
Journal:  Toxicol Res (Camb)       Date:  2016-06-07       Impact factor: 3.524

3.  Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Authors:  Masahiro Kusumoto; Hiroki Kamobayashi; Daisuke Sato; Megumi Komori; Misato Yoshimura; Akinobu Hamada; Yukimasa Kohda; Kimio Tomita; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

Review 4.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  MATE-1 modulation by kinin B1 receptor enhances cisplatin efflux from renal cells.

Authors:  Gabriel R Estrela; Frederick Wasinski; Raphael J F Felizardo; Laura L Souza; Niels O S Câmara; Michael Bader; Ronaldo C Araujo
Journal:  Mol Cell Biochem       Date:  2017-02-04       Impact factor: 3.396

6.  Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.

Authors:  Dengpiao Xie; Gaizun Hu; Chaoling Chen; Fereshteh Ahmadinejad; Weili Wang; Pin-Lan Li; David A Gewirtz; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-14

7.  Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats.

Authors:  Koji Yokoo; Risa Murakami; Takanobu Matsuzaki; Kanako Yoshitome; Akinobu Hamada; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2009-07-24       Impact factor: 2.801

8.  Exploring the potential of flunarizine for Cisplatin-induced painful uremic neuropathy in rats.

Authors:  Arunachalam Muthuraman; Sumeet Kumar Singla; Anil Peters
Journal:  Int Neurourol J       Date:  2011-09-30       Impact factor: 2.835

9.  Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury.

Authors:  Tomohiro Mizuno; Waichi Sato; Kazuhiro Ishikawa; Yuki Terao; Kazuo Takahashi; Yukihiro Noda; Yukio Yuzawa; Tadashi Nagamatsu
Journal:  Onco Targets Ther       Date:  2015-07-10       Impact factor: 4.147

10.  Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1.

Authors:  Chang-Ching Lin; Hsien-Yuan Fan; Chien-Wen Kuo; Li-Heng Pao
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.